Jolly Good/Teijin Pharma Develop VR Digital Therapeutics for Depression

"Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder.

The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA).

Jolly Good has already won a “Home Healthcare Award” in a programme held by Teijin in December last year.

The partnership will be based on Jolly Good’s technology and Teijin’s strategic expertise, the companies said.

Jolly Good is a medical technology company that develops VR solutions and AI-based medical and welfare services that analyse user behaviour in the VR space..." Lire la suite